{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:11:43Z","timestamp":1791047503448,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.neuropharm.2005.08.004","type":"journal-article","created":{"date-parts":[[2005,9,22]],"date-time":"2005-09-22T11:21:12Z","timestamp":1127388072000},"page":"1220-1227","source":"Crossref","is-referenced-by-count":79,"title":["Ambroxol, a Nav1.8-preferring Na+ channel blocker, effectively suppresses pain symptoms in animal models of chronic, neuropathic and inflammatory pain"],"prefix":"10.1016","volume":"49","author":[{"given":"Wolfram","family":"Gaida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Klinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Arndt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Weiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.neuropharm.2005.08.004_bib1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/713745174","article-title":"Stable expression and characterization of human PN1 and PN3 sodium channels","volume":"9","author":"Akiba","year":"2003","journal-title":"Receptors and Channels"},{"issue":"3","key":"10.1016\/j.neuropharm.2005.08.004_bib2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.neulet.2004.07.091","article-title":"Gabapentin relieves mechanical, warm and cold allodynia in a rat model of peripheral neuropathy","volume":"368","author":"Back","year":"2004","journal-title":"Neuroscience Letters"},{"issue":"1","key":"10.1016\/j.neuropharm.2005.08.004_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0165-6147(00)01585-6","article-title":"Involvement of Na+ channels in pain pathways","volume":"22","author":"Baker","year":"2001","journal-title":"Trends in Pharmacological Science"},{"issue":"1","key":"10.1016\/j.neuropharm.2005.08.004_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2005.08.004_bib5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0304-3959(98)00043-8","article-title":"Attenuation of formalin-induced nociceptive behaviors following local peripheral injection of gabapentin","volume":"76","author":"Carlton","year":"1998","journal-title":"Pain"},{"issue":"1\/2","key":"10.1016\/j.neuropharm.2005.08.004_bib6","first-page":"1","article-title":"The prevention of postoperative ARDS. Double-blind clinical testing about the effects of ambroxol on pulmonary gas exchange","volume":"6","author":"Chiara","year":"1983","journal-title":"Urgentis Chirurgiae Commentaria"},{"issue":"9","key":"10.1016\/j.neuropharm.2005.08.004_bib7","first-page":"467","article-title":"Steady-state bioavailability and pharmacokinetics of ambroxol and clenbuterol administered alone or combined in a new oral formulation. International Journal of Clinical Pharmacology","volume":"27","author":"Couet","year":"1989","journal-title":"Therapy and Toxicology"},{"key":"10.1016\/j.neuropharm.2005.08.004_bib8","first-page":"74","article-title":"A method for determining loss of pain sensation","volume":"72","author":"D'Amour","year":"1941","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"3","key":"10.1016\/j.neuropharm.2005.08.004_bib9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0014-2999(02)02792-9","article-title":"A comparison of the antinociceptive effects of voltage-activated Na+ channel blockers in two rat models of neuropathic pain","volume":"458","author":"Erichsen","year":"2003","journal-title":"European Journal of Pharmacology"},{"issue":"11","key":"10.1016\/j.neuropharm.2005.08.004_bib10","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2165\/00044011-200424110-00007","article-title":"Ambroxol lozenge bioavailability: part II \u2013 analysis of additional systemic availability","volume":"24","author":"Faroongsarng","year":"2004","journal-title":"Clinical Drug Investigation"},{"key":"10.1016\/j.neuropharm.2005.08.004_bib11","first-page":"91","article-title":"The analgesic response to intravenous lidocaine in the treatment of neuropathic pain","volume":"82","author":"Ferrante","year":"1996","journal-title":"Anaesthesia and Analgesia"},{"issue":"2","key":"10.1016\/j.neuropharm.2005.08.004_bib12","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1124\/jpet.102.033134","article-title":"Gabapentin and the neurokinin(1) receptor antagonist CI-1021 act synergistically in two rat models of neuropathic pain","volume":"303","author":"Field","year":"2002","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2005.08.004_bib13","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0304-3959(98)00239-5","article-title":"Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat","volume":"80","author":"Field","year":"1999","journal-title":"Pain"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2005.08.004_bib14","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0304-3959(03)00253-7","article-title":"Comparative activity of the anti-convulsants oxcarbazepine, carbamazepine, lamotrigine and gabapentin in a model of neuropathic pain in the rat and guinea-pig","volume":"105","author":"Fox","year":"2003","journal-title":"Pain"},{"issue":"10","key":"10.1016\/j.neuropharm.2005.08.004_bib15","first-page":"1398","article-title":"General pharmacological studies on N-(2,6-dimethylphenyl)-8- pyrrolizidineacetamide hydrochloride hemihydrate. 1st Communication: effect on the central nervous system","volume":"38","author":"Hirotsu","year":"1988","journal-title":"Arzneimittelforschung (Drug Research)"},{"issue":"2\u20133","key":"10.1016\/j.neuropharm.2005.08.004_bib16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0014-2999(97)00070-8","article-title":"The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain","volume":"324","author":"Hunter","year":"1997","journal-title":"European Journal of Pharmacology"},{"issue":"5","key":"10.1016\/j.neuropharm.2005.08.004_bib17","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1097\/00000542-200211000-00033","article-title":"Gabapentin and pregabalin can interact synergistically with naproxen to produce antihyperalgesia","volume":"97","author":"Hurley","year":"2002","journal-title":"Anesthesiology"},{"issue":"9","key":"10.1016\/j.neuropharm.2005.08.004_bib18","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3109\/00498259109039555","article-title":"Tissue distribution of mexiletine enantiomers in rats","volume":"21","author":"Igwemezie","year":"1991","journal-title":"Xenobiotica"},{"issue":"4","key":"10.1016\/j.neuropharm.2005.08.004_bib19","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2165\/00003495-199856040-00016","article-title":"Mexiletine: a review of its therapeutic use in painful diabetic neuropathy","volume":"56","author":"Jarvis","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.neuropharm.2005.08.004_bib20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0140-6736(76)90272-5","article-title":"Fatal mexiletine overdose","volume":"1","author":"Jequier","year":"1976","journal-title":"Lancet"},{"issue":"1\/2","key":"10.1016\/j.neuropharm.2005.08.004_bib21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0304-3959(96)03231-9","article-title":"The effects of mexiletine, desipramine and fluoxetine in rat models involving central sensitization","volume":"69","author":"Jett","year":"1997","journal-title":"Pain"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2005.08.004_bib22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1440-1681.2004.03950.x","article-title":"Oxcarbazepine antinociception in animals with inflammatory pain or painful diabetic neuropathy","volume":"31","author":"Kiguchi","year":"2004","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"issue":"3","key":"10.1016\/j.neuropharm.2005.08.004_bib23","first-page":"204","article-title":"Antenatal ambroxol usage in the prevention of infant respiratory distress syndrome - beneficial and adverse effects","volume":"22","author":"Kimya","year":"1995","journal-title":"Clinical and Experimental Obstetrics and Gynecology"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2005.08.004_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0304-3959(01)00391-8","article-title":"Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, NaV1.8","volume":"95","author":"Lai","year":"2002","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.neuropharm.2005.08.004_bib25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.phrs.2003.07.011","article-title":"Bioequivalence assessment of ambroxol tablet after a single oral dose administration to healthy male volunteers","volume":"49","author":"Lee","year":"2004","journal-title":"Pharmacological Research"},{"issue":"8","key":"10.1016\/j.neuropharm.2005.08.004_bib26","first-page":"541","article-title":"Bioequivalence evaluation of domestic ambroxol hydrochloride tablets in healthy subjects","volume":"34","author":"Li","year":"1999","journal-title":"Chinese Pharmacological Journal (Beijing)"},{"key":"10.1016\/j.neuropharm.2005.08.004_bib27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1515\/jpme.1987.15.3.227","article-title":"An alternative to steroids for prevention of respiratory distress syndrome (RDS): multicenter controlled study to compare ambroxol and betamethasone","volume":"15","author":"Luerti","year":"1987","journal-title":"Journal of Perinatal Medicine"},{"issue":"3","key":"10.1016\/j.neuropharm.2005.08.004_bib28","first-page":"179","article-title":"A pharmacokinetic study on pulmonary tropism of ambroxol in patients under thoracic surgery","volume":"13","author":"Mezzetti","year":"1990","journal-title":"Journal of Emergency Surgery and Intensive Care"},{"key":"10.1016\/j.neuropharm.2005.08.004_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.2042-7158.1992.tb14364.x","article-title":"Salivary excretion of mexiletine after bolus intravenous administration in rats","volume":"44","author":"Nagasako","year":"1992","journal-title":"Journal of Pharmacy and Pharmacology"},{"key":"10.1016\/j.neuropharm.2005.08.004_bib30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0378-4347(92)80278-X","article-title":"High-performance liquid chromatographic determination of ambroxol in human plasma","volume":"581","author":"Nobilis","year":"1992","journal-title":"Journal of Chromatography (B) Biomedical Applications"},{"key":"10.1016\/j.neuropharm.2005.08.004_bib31","first-page":"503","article-title":"Pharmacokinetics and the anti-arrhythmic effect of mexiletine in patients with chronic ventricular arrhythmias","volume":"34","author":"Ohashi","year":"1984","journal-title":"Arzneimittelforschung (Drug Research)"},{"issue":"3","key":"10.1016\/j.neuropharm.2005.08.004_bib32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF00271364","article-title":"Dose-dependent uricosuric effect of ambroxol","volume":"44","author":"Oosterhuis","year":"1993","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2005.08.004_bib33","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0304-3959(00)00404-8","article-title":"The effects of GABA(B) agonists and gabapentin on mechanical hyperalgesia in models of neuropathic and inflammatory pain in the rat","volume":"90","author":"Patel","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2005.08.004_bib34","first-page":"889","article-title":"Pharmacological study on the bromhexine-metabolite ambroxol","volume":"28","author":"P\u00fcschmann","year":"1978","journal-title":"Arzneimittelforschung (Drug Research)"},{"issue":"6","key":"10.1016\/j.neuropharm.2005.08.004_bib35","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/jat\/18.6.354","article-title":"Postmortem distribution of mexiletine in a fatal overdose","volume":"18","author":"Rohrig","year":"1994","journal-title":"Journal of Analytical Toxicology"},{"issue":"4","key":"10.1016\/j.neuropharm.2005.08.004_bib36","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/00044011-200323040-00007","article-title":"Ambroxol lozenge bioavailability: an open-label, two-way crossover study of the comparative bioavailability of ambroxol lozenges and commercial tablets in healthy Thai volunteers","volume":"23","author":"Rojpibulstit","year":"2003","journal-title":"Clinical Drug Investigation"},{"issue":"5","key":"10.1016\/j.neuropharm.2005.08.004_bib37","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.0003-2409.2001.02399.x","article-title":"Gabapentin: pharmacology and its use in pain management","volume":"57","author":"Rose","year":"2002","journal-title":"Anaesthesia"},{"issue":"8","key":"10.1016\/j.neuropharm.2005.08.004_bib38","first-page":"2","article-title":"Ambroxol in the treatment of ARDS in polytraumatised patients \u2013 a report","volume":"21","author":"Schillings","year":"1992","journal-title":"Klinikarzt"},{"key":"10.1016\/j.neuropharm.2005.08.004_bib39","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1152\/jn.1998.79.4.1746","article-title":"Complex blockade of TTX-resistant Na+ currents by lidocaine and bupivacaine reduce firing frequency in DRG neurons","volume":"79","author":"Scholz","year":"1998","journal-title":"Journal of Neurophysiology"},{"key":"10.1016\/j.neuropharm.2005.08.004_bib40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0304-3959(00)00345-6","article-title":"Tetrodotoxin-resistant action potentials in dorsal root ganglion neurons are blocked by local anesthetics","volume":"89","author":"Scholz","year":"2000","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.neuropharm.2005.08.004_bib41","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0304-3959(90)91074-S","article-title":"A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury","volume":"43","author":"Seltzer","year":"1990","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.neuropharm.2005.08.004_bib42","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1526-5900(00)90098-1","article-title":"Enantioselective relief of neuropathic pain by systemic mexiletine in the rat","volume":"1","author":"Sinnott","year":"2000","journal-title":"Journal of Pain"},{"issue":"10","key":"10.1016\/j.neuropharm.2005.08.004_bib43","first-page":"1591","article-title":"Pharmacokinetics and bioequivalence of different formulations of ambroxol","volume":"35","author":"Vergin","year":"1985","journal-title":"Arzneimittelforschung (Drug Research)"},{"issue":"8","key":"10.1016\/j.neuropharm.2005.08.004_bib44","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/S0149-2918(03)80215-1","article-title":"Pharmacokinetic properties of single-dose loratadine and ambroxol alone and combined in tablet formulations in healthy men","volume":"25","author":"Villacampa","year":"2003","journal-title":"Clinical Therapeutics"},{"issue":"5","key":"10.1016\/j.neuropharm.2005.08.004_bib45","first-page":"830","article-title":"Pharmacokinetics and metabolism of gabapentin in rat, dog and man","volume":"36","author":"Vollmer","year":"1986","journal-title":"Arzneimittelforschung (Drug Research)"},{"key":"10.1016\/j.neuropharm.2005.08.004_bib46","first-page":"263","article-title":"Toxicological studies on ambroxol (NA-872). (1) Acute toxicity in mice and rats","volume":"12","author":"Wada","year":"1981","journal-title":"Iyakuhin Kenkyu"},{"issue":"6","key":"10.1016\/j.neuropharm.2005.08.004_bib47","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1124\/mol.56.6.1238","article-title":"Differential interaction of R-mexiletine with the local anesthetic receptor site on brain and heart sodium channel alpha-subunits","volume":"56","author":"Weiser","year":"1999","journal-title":"Molecular Pharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2005.08.004_bib48","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1124\/mol.62.3.433","article-title":"Inhibition of tetrodotoxin (TTX)-resistant and TTX-sensitive neuronal Na(+) channels by the secretolytic ambroxol","volume":"62","author":"Weiser","year":"2002","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.neuropharm.2005.08.004_bib50","first-page":"300","article-title":"The evaluation of the analgesic action of pethidine hydrochloride (Demerol)","volume":"80","author":"Woolfe","year":"1944","journal-title":"Journal of Pharmacology and Experimental Therapeutics"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390805003084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390805003084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T16:23:55Z","timestamp":1553531035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390805003084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0028390805003084"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2005.08.004","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}